Polyneuropathy associated with interferon beta treatment in patients with multiple sclerosis

Neurology. 2005 Aug 9;65(3):456-8. doi: 10.1212/01.wnl.0000171858.82527.4c.

Abstract

Peripheral neuropathy has been reported as a side effect of interferon alpha, but not with interferon beta (IFNbeta) treatment. The authors assessed six patients with multiple sclerosis who developed polyneuropathy, or had exacerbation of previously subclinical neuropathy, during treatment with IFNbeta. In five patients the neuropathy improved after discontinuation of treatment and in two patients it relapsed upon rechallenge.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Disease Progression
  • Female
  • Humans
  • Interferon beta-1a
  • Interferon beta-1b
  • Interferon-beta / adverse effects*
  • Male
  • Middle Aged
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / immunology
  • Neural Conduction / drug effects
  • Neural Conduction / immunology
  • Paresis / chemically induced
  • Paresis / immunology
  • Paresis / physiopathology
  • Peripheral Nerves / drug effects*
  • Peripheral Nerves / immunology
  • Peripheral Nerves / physiopathology
  • Polyneuropathies / chemically induced*
  • Polyneuropathies / immunology
  • Polyneuropathies / physiopathology
  • Recurrence
  • Sensation Disorders / chemically induced
  • Sensation Disorders / immunology
  • Sensation Disorders / physiopathology

Substances

  • Interferon beta-1b
  • Interferon-beta
  • Interferon beta-1a